Topiramate Tablet, Film Coated
Product Images NDC 68084-345

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 68084-345). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100 mg Blister

Sheet containing multiple identical labels for Topiramate tablets, USP 100 mg, film-coated, oral dosage form. Each label includes the product name, strength, dosage form, a barcode, expiration date placeholder, lot number placeholder, and manufacturer information for American Health Packaging, Columbus, Ohio.*

FDA Label Image

100 mg Carton

Topiramate 100 mg tablets label showing dosage form as film-coated oral tablets, with a package size of 100 tablets (10 x 10). The label includes NDC 68084-344-01 and states the drug is prescription only. It is distributed by American Health Packaging, Columbus, Ohio. Storage and handling instructions are also visible.*

FDA Label Image

200 mg Blister

Label sheet showing multiple identical film-coated tablet labels for Topiramate 200 mg. Each label includes the product name, dosage form, strength, barcode, lot number, and expiration date placeholders. The labeler is American Health Packaging, Columbus, Ohio.*

FDA Label Image

200 mg Carton

Topiramate 200 mg film-coated tablets label from American Health Packaging. It displays the product name, strength, dosage form, package size of 30 tablets (3 x 10), NDC 68084-345-21, and usage instructions including storage conditions and warnings. The label also includes a barcode and pharmacist dispensing notes.*

FDA Label Image

25 mg Blister

Topiramate 25 mg film-coated tablet label from American Health Packaging. Each label includes the product name, strength, dosage form, bar code, NDC number, and fields for lot number and expiration date. The label is designed for oral administration and displays the labeler's location as Columbus, Ohio.*

FDA Label Image

25 mg Carton

Topiramate 25 mg tablets, USP, film-coated oral tablets in a 100-count package (10 blister cards of 10 tablets). The label includes prescription-only status, NDC 68084-342-01, pharmacist instructions, storage conditions at 20° to 25°C, and packaging information by American Health Packaging in Columbus, Ohio.*

FDA Label Image

50 mg Blister

Label sheet for Topiramate tablets, USP 50 mg, film coated oral tablets. The label displays multiple identical printed sections containing the drug name, strength (50 mg), barcodes, expiration and lot information placeholders, and the labeler American Health Packaging, Columbus, Ohio address.*

FDA Label Image

50 mg Carton

Topiramate 50 mg film-coated tablets label showing 100 count (10 x 10) packaged by American Health Packaging. The label includes the NDC 68084-343-01 and instructions for pharmacists to dispense a medication guide, storage temperature guidelines, and safety warnings. The product is for oral use and prescription only.*

FDA Label Image

Ahp34201

Topiramate 100 mg film-coated oral tablet. The round white tablet is imprinted with 'ZD 16' on one side and is plain on the other. Manufactured by American Health Packaging.*

FDA Label Image

Ahp34301

Topiramate 15 mg round, white, film-coated oral tablet with imprint "ZD 15" on one side and plain on the other side, shown with a millimeter scale for size reference.*

FDA Label Image

Ahp34401

Topiramate 25 mg film-coated tablet, round, white, with imprint "ZD 14" on one side and a blank other side. The image includes a millimeter scale for size reference. Labeled by American Health Packaging.*

FDA Label Image

Ahp34521

Topiramate 100 mg film-coated round white oral tablets, imprinted with 'ZD 13' on one side and blank on the other. Manufactured by American Health Packaging.*

FDA Label Image

Figure 1

A Kaplan-Meier plot illustrating cumulative rates for time to first seizure in a study comparing two doses of Topiramate: 50 mg/day and 400 mg/day. The x-axis represents time in days up to 500, and the y-axis shows cumulative seizure rates. The graph includes lines for each dose group with 234 and 236 participants, respectively, and a p-value of 0.0002.*

FDA Label Image

Figure 2

A bar chart comparing the change from baseline to double-blind phase in average monthly migraine period rate for Placebo, and Topiramate at doses of 50 mg/day, 100 mg/day, and 200 mg/day in two separate studies. The y-axis shows change values with error bars representing standard error. Statistical significance levels are indicated with asterisks below some bars.*

FDA Label Image

Structure

Chemical structure diagram of Topiramate, illustrating its molecular bonds and arrangement, as depicted in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.